Alti Global, Inc. (ALTI) Stock Price & Analysis
Alti Global, Inc. (ALTI) rose 2.71% to USD 3.41 as of July 25, 2026 at 06:09 UTC, according to Nexqual real-time market data.
ALTI last closed at USD 3.32; the session ranged USD 3.3–3.46 on volume of 46,572 shares. Market capitalization is $517.02M, with a 52-week range of USD 2.75–5.45 (NCM). Source: Nexqual, July 25, 2026 at 06:09 UTC.
Key Statistics (as of July 25, 2026 at 06:09 UTC)
| Price | USD 3.41 |
|---|---|
| Change | ▲ 2.71% (up) |
| Previous Close | USD 3.32 |
| Open | USD 3.35 |
| Day Range | USD 3.3 – 3.46 |
| 52-Week Range | USD 2.75 – 5.45 |
| Volume | 46,572 shares |
| Market Cap | $517.02M |
| Exchange | NCM |
Technical Analysis (ALTI)
Nexqual's technical model rates ALTI "NEUTRAL" based on 2 bullish and 3 bearish signals across 125 daily candles, as of July 25, 2026 at 06:09 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 50.64 (neutral) |
| vs SMA50 | Above (USD 3.34) |
| MACD | 0.02 (positive) |
Analyst Ratings (ALTI)
Wall Street analysts rate ALTI "None" based on 1 analysts, with a mean price target of USD 9 (range USD 9–9), per Nexqual as of July 25, 2026 at 06:09 UTC.
| Consensus Rating | None |
|---|---|
| Analyst Count | 1 |
| Mean Target | USD 9 |
| High Target | USD 9 |
| Low Target | USD 9 |
| Buy / Hold / Sell | 1 / 0 / 0 |
Earnings (ALTI)
| Next Earnings Date | 2026-08-10 |
|---|---|
| EPS Estimate | USD 0.06 |
| Revenue Estimate | $61.80M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-03-31 | USD 0.08 vs est 0.06 ▲ beat |
| 2025-12-31 | USD 0.1 vs est 0.02 ▲ beat |
| 2025-09-30 | USD 0.01 vs est 0.03 ▼ miss |
| 2025-06-30 | USD -0.01 vs est 0 ▼ miss |
Source: Nexqual, July 25, 2026 at 06:09 UTC.
Financials & Fundamentals (ALTI)
| Total Revenue | $270.97M |
|---|---|
| Revenue Growth (YoY) | +28.10% |
| Gross Margin | +25.76% |
| Operating Margin | -14.59% |
| Profit Margin | -42.03% |
| ROE | -12.87% |
| Debt / Equity | 8.59 |
| Current Ratio | 1.1 |
| Total Cash | $39.72M |
| Total Debt | $75.83M |
| Free Cash Flow | $26.53M |
Source: Nexqual, July 25, 2026 at 06:09 UTC.
Financial Health Score (ALTI)
Nexqual rates Alti Global, Inc.'s overall financial health "Mixed" across five dimensions, as of July 25, 2026 at 06:09 UTC.
| Growth | Strong — Revenue +23% YoY (annual) |
|---|---|
| Profitability | Weak — Gross margin 26%, operating -15% |
| Balance Sheet | Strong — $40M cash vs $76M debt |
| Cash Flow | Solid — FCF $27M, 10% margin |
| Efficiency | Critical — ROE -13%, ROA -3.7% |
Ownership (ALTI)
| Insider Ownership | +55.27% |
|---|---|
| Institutional Ownership | +15.32% |
| Shares Outstanding | 110.74M |
| Float | 48.12M |
| Short % of Float | +2.71% |
Source: Nexqual, July 25, 2026 at 06:09 UTC.
Leadership (ALTI)
Alti Global, Inc. is led by Nancy Curtin, Global Chief Investment Officer, Interim CEO & Director, per Nexqual as of July 25, 2026 at 06:09 UTC.
| Global Chief Investment Officer, Interim CEO & Director | Nancy Curtin |
|---|---|
| President & COO | Kevin Patirck Moran (age 47) |
| CFO & Chief Accounting Officer | Patrick Keenan (age 35) |
| Chief Technology Officer | Phillip Dundas |
| Chief Marketing Officer | Claire Verdirame |
Major Backers & Investors (ALTI)
Notable institutional backers of Alti Global, Inc. include Fidelity, Alti Global, Inc., Yorkville Advisors Global, LP, according to Nexqual as of July 25, 2026 at 06:09 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Fidelity | 0.7% |
| Alti Global, Inc. | 0.7% |
| Yorkville Advisors Global, LP | 0.7% |
| BOKF, NA | 0.32% |
| Charles Schwab Investment Management, Inc. | 0.31% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Allianz SE | 19.6% |
| BlackRock | 3.71% |
| Vanguard Group | 3.11% |
| Geode Capital | 1.04% |
| State Street | 0.75% |
Source: Nexqual, July 25, 2026 at 06:09 UTC.
From Alti Global, Inc.'s Latest SEC 10-K Filing (filed 2026-03-31)
Key Strengths & Strategy (as disclosed to the SEC)
- We have offices located in 19 leading financial centers, in 9 countries across the U.S., Europe and Asia, which enables us to service our clients across multiple jurisdictions.
- Our global distribution platform in our alternatives business also enables us to reach clients across three continents.
- We expect to continue to diligently evaluate and execute inorganic opportunities which will enhance our platform by broadening our global footprint or enabling us to expand our product offerings.
Partnerships
- Strategic Partners - Allianz and Constellation In February 2024, we announced our strategic relationship with Allianz and Constellation, for a combined investment of up to $450 million into AlTi.
- We also provide our wealth management clients with access to alternative investment opportunities, including investments in strategies and asset classes to which they would otherwise likely not be able to gain exposure.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| SLSN | Solesence, Inc. | USD 0.94 | ▲ 10.59% |
| NGEN | NervGen Pharma Corp. | USD 1.63 | ▼ 5.23% |
| NVEC | NVE Corporation | USD 117.55 | ▲ 35.61% |
| ACCL | Acco Group Holdings Limited | USD 2.13 | ▼ 0.47% |
| VECO | Veeco Instruments Inc. | USD 51.66 | ▼ 5.38% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 06:09 UTC. This page is informational and not investment advice.